Research Scientist
Gilead Sciences
Foster City, California
Dr. Krishna Anapindi is currently a Research Scientist at Gilead Sciences, based in Foster City, California, a role he has been dedicated to since September 2022. At Gilead, Dr. Anapindi spearheads projects with the Molecular Assessment team, concentrating on the developability of diverse protein therapeutic modalities. His innovative contributions include the development of new experimental and computational workflows, incorporating machine learning techniques, to assess and enhance the developability properties of therapeutic proteins.
Prior to his current role, Dr. Anapindi was a Senior Scientist I at AbbVie in North Chicago, Illinois, from August 2020 to August 2022. In this role, he coordinated comparability, forced degradation, and extended characterization support for Antibody Drug Conjugates (ADC). He also led initiatives in automation and machine learning as the subject matter expert, developing and implementing sample handling and data processing workflows to streamline ADC development. His responsibilities included ensuring compliance with FDA, cGMP, and ICH regulatory requirements, supporting regulatory filings, writing Investigational New Drug (IND) applications, and managing method transfers and training.
He has a PhD in Analytical Chemistry and a Masters in Applied Statistics from the University of Illinois at Urbana-Champaign.
Disclosure information not submitted.
High-Speed Microdroplet Reactions for Faster Therapeutic Protein Analysis
Tuesday, May 14, 2024
11:15 AM – 12:00 PM PT